-Live Mint There is no dearth of advisors for a government considered to be in the grip of a policy paralysis and whose prime minister is dubbed an “underachiever”. In this season of India-bashing, US President Barack Obama spared some time from his election campaign and offered some pearly words of wisdom on the Indian economy. This came at a time when in his own backyard, thousands of people marched in...
More »SEARCH RESULT
Back off, angry govt tells Obama
-The Times of India A day after US President Barack Obama's call for lifting of foreign investment curbs by India, the government on Monday shot back asking Washington not to meddle with the country's internal affairs and suggested that the world's largest economy should lead the fight against protectionism. The statement came amid protests from the Opposition, which asked the government not succumb to US pressure. "He (Obama) has every right to...
More »FDI in multibrand retail will not further reform agenda-Manoj Pant
-The Economic Times The crisis of the euro, a current account deficit of over 4%, double-digit inflation, corruption in governance and a failing political system. It would not be unfair to say that these factors have combined in varying degrees at different times to lead to the conclusion that the globally-acclaimed India growth story seems to be heading for an unhappy ending. Many have labelled this - unfairly, I think - as...
More »PIL against Bharti Walmart, Delhi high court seeks response
-The Times of India The Delhi high court on Wednesday sought replies from the Centre, Bharti Walmart Private Limited and Bharti Retail Limited on a plea for a probe against the firms for allegedly carrying out retail trading in multi-brand sector in violation of India's FDI policy. A bench of acting Chief Justice AK Sikri and Justice Anil Kumar issued notices to the Centre and the firms on a PIL filed by...
More »Dogged with corruption, drug regulation is in poor health and ineffective-Khomba Singh
-The Economic Times It's not just the drug regulator, where a parliamentary panel has alleged corruption, failing in its job. Drug regulation across entities that dot this broad landscape is in poor health and ineffective. In May, when a Parliamentary panel, during a routine examination of healthcare regulatory bodies, alleged corruption in the approval of new drugs, it was merely pointing out one symptom. Such symptoms pervade the entire drug regulation landscape,...
More »